Literature DB >> 11517329

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.

V Rubio-Godoy1, V Dutoit, D Rimoldi, D Lienard, F Lejeune, D Speiser, P Guillaume, J C Cerottini, P Romero, D Valmori.   

Abstract

Activation of CD8(+) cytolytic T lymphocytes (CTLs) by antigen is triggered by the interaction of clonotypic alphabeta T cell receptors (TCRs) with antigenic peptides bound to MHC class I molecules (pMHC complexes). Fluorescent multimeric pMHC complexes have been shown to specifically stain antigen-specific CTLs by directly binding the TCR. In tumor-infiltrating lymphocytes from a melanoma patient we found a high frequency of tyrosinase(368-376) peptide-specific cells as detected by IFN-gamma ELISPOT, without detectable staining with the corresponding A2/peptide multimers. Surprisingly, these T cells were able to lyse tyrosinase(368-376) peptide-pulsed target cells as efficiently as other specific T cells that were stained by multimers. Analysis of the staining patterns under different conditions of incubation time and temperature revealed that these results were explained by major differences in TCR-multimeric ligand interaction kinetics among the clones. Whereas no direct quantitative correlation between antigenic peptide concentration required for CTL effector functions and equilibrium multimer binding was observed interclonally, the latter was profoundly affected by the kinetics of TCR-ligand interaction. More importantly, our data indicate that similar levels of T cell activation can be achieved by independent CD8(+) T cell clonotypes displaying different TCR/pMHC complex dissociation rates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517329      PMCID: PMC56956          DOI: 10.1073/pnas.181348898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Kinetic discrimination in T-cell activation.

Authors:  J D Rabinowitz; C Beeson; D S Lyons; M M Davis; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

2.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists.

Authors:  D S Lyons; S A Lieberman; J Hampl; J J Boniface; Y Chien; L J Berg; M M Davis
Journal:  Immunity       Date:  1996-07       Impact factor: 31.745

3.  Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity.

Authors:  B A Schodin; T J Tsomides; D M Kranz
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

Review 4.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology.

Authors:  J Sloan-Lancaster; P M Allen
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Kinetic proofreading in T-cell receptor signal transduction.

Authors:  T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes.

Authors:  Y Sykulev; R J Cohen; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

7.  CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes.

Authors:  K C Garcia; C A Scott; A Brunmark; F R Carbone; P A Peterson; I A Wilson; L Teyton
Journal:  Nature       Date:  1996-12-12       Impact factor: 49.962

8.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Authors:  J C Skipper; R C Hendrickson; P H Gulden; V Brichard; A Van Pel; Y Chen; J Shabanowitz; T Wolfel; C L Slingluff; T Boon; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.

Authors:  B M Kessler; P Bassanini; J C Cerottini; I F Luescher
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  29 in total

1.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  Multiple costimulatory modalities enhance CTL avidity.

Authors:  James W Hodge; Mala Chakraborty; Chie Kudo-Saito; Charlie T Garnett; Jeffrey Schlom
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

3.  Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.

Authors:  Sixun Yang; Kwong-Yok Tsang; Jeffrey Schlom
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

4.  Transduction of primary lymphocytes with Epstein-Barr virus (EBV) latent membrane protein-specific T-cell receptor induces lysis of virus-infected cells: A novel strategy for the treatment of Hodgkin's disease and nasopharyngeal carcinoma.

Authors:  Lisa A Jurgens; Rajiv Khanna; James Weber; Rimas J Orentas
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

5.  Nondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.

Authors:  Jennifer N Uram; Chelsea M Black; Emilee Flynn; Lanqing Huang; Todd D Armstrong; Elizabeth M Jaffee
Journal:  J Immunol       Date:  2011-02-23       Impact factor: 5.422

6.  An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.

Authors:  Nishant K Singh; Jesus A Alonso; Daniel T Harris; Scott D Anderson; Jiaqi Ma; Lance M Hellman; Aaron M Rosenberg; Elizabeth M Kolawole; Brian D Evavold; David M Kranz; Brian M Baker
Journal:  Biochemistry       Date:  2020-10-19       Impact factor: 3.162

7.  T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.

Authors:  Pablo A González; Leandro J Carreño; Daniel Coombs; Jorge E Mora; Edith Palmieri; Byron Goldstein; Stanley G Nathenson; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

8.  The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.

Authors:  Leandro J Carreño; Susan M Bueno; Paulina Bull; Stanley G Nathenson; Alexis M Kalergis
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

9.  Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.

Authors:  Hamid Echchakir; Guillaume Dorothée; Isabelle Vergnon; Jeanne Menez; Salem Chouaib; Fathia Mami-Chouaib
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

Review 10.  Tricks with tetramers: how to get the most from multimeric peptide-MHC.

Authors:  Linda Wooldridge; Anna Lissina; David K Cole; Hugo A van den Berg; David A Price; Andrew K Sewell
Journal:  Immunology       Date:  2009-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.